Subaortic Membrane #3: Surgical Procedure

image

1. Introduction

Surgical treatment of a subaortic membrane aims to relieve fixed left ventricular outflow tract (LVOT) obstruction while preserving the structural and functional integrity of the aortic valve, mitral valve, ventricular septum, and cardiac conduction system.

Discrete subaortic stenosis is characterized by a fibrous or fibromuscular membrane beneath the aortic valve. The lesion may appear as a thin crescentic ridge, a nearly circumferential membrane, or more extensive fibromuscular narrowing involving the interventricular septum and aortomitral continuity.

The standard surgical approach is transaortic membrane resection, with selective septal myectomy when associated muscular hypertrophy contributes to obstruction. This permits direct visualization of the LVOT through the aortic valve without requiring a ventriculotomy. [1,2]

Although surgical relief is generally effective, recurrence and progressive aortic regurgitation remain important late concerns.

2. Surgical Anatomy and Structures at Risk

2.1. Relationship Between the Aortic Valve and LVOT

The subaortic membrane typically develops along the ventricular aspect of the LVOT, frequently involving the basal interventricular septum and fibrous continuity between the aortic and mitral valves.

The LVOT is bounded by:

  • Anterior and rightward: Basal interventricular septum, including the muscular and adjacent membranous septum.
  • Posterior and leftward: Anterior mitral leaflet and aortomitral fibrous continuity.
  • Superiorly: Aortic valve leaflets and their hinge regions.
  • Inferiorly: Muscular LVOT toward the ventricular cavity.

Fibrous extensions may attach to the ventricular surface or basal attachments of aortic cusps, raising the risk of valve injury during dissection. Thin high membranes and more extensive fibromuscular lesions are distinct points along a morphological spectrum. [3]

2.2. Aortomitral Continuity and Anterior Mitral Leaflet

The anterior mitral leaflet forms much of the posterior LVOT boundary. Fibrous tissue may extend from the septum toward the anterior leaflet, forming a partially circumferential obstruction.

The surgeon must distinguish pathological tissue from the normal supporting fibrous skeleton. Excessive excision along this region risks anterior mitral leaflet perforation, disruption of its attachment, mitral regurgitation, or injury to adjacent aortic cusp attachments.

2.3. Membranous Septum and Conduction Tissue

The membranous septum lies beneath the right–noncoronary aortic cusp region. The penetrating atrioventricular conduction axis passes through the central fibrous body, placing the His bundle and proximal branches near the membranous septum.

Deep resection or septal myectomy in this region can produce atrioventricular block. Anatomical variation, particularly with associated congenital defects, must be considered rather than relying exclusively on a single landmark.

3. Preoperative Evaluation and Surgical Planning

3.1. Echocardiography

Transthoracic echocardiography should define:

  1. Distance from the membrane to the aortic valve.
  2. Circumferential extent and attachment sites.
  3. Muscular septal hypertrophy or tunnel-like narrowing.
  4. Peak and mean LVOT Doppler gradients.
  5. Aortic regurgitation severity and mechanism.
  6. Associated lesions, including ventricular septal defect, bicuspid aortic valve, and multilevel left-heart obstruction.

The Doppler gradient depends on flow and loading conditions. A peak instantaneous Doppler gradient is not equivalent to an invasive peak-to-peak gradient.

3.2. Indications and Timing

Surgery is considered for significant or progressive obstruction, attributable symptoms, adverse ventricular remodeling, or clinically relevant aortic valve involvement. Progressive aortic regurgitation can influence intervention even when obstruction is not severe.

Published approaches use differing gradient thresholds; no single threshold applies universally to all pediatric patients. Decision-making should incorporate anatomy, progression, ventricular loading, aortic valve findings, and age. [2,4]

Earlier surgery may limit prolonged abnormal flow exposure, but younger age has been associated with recurrence in observational cohorts. [5,6]

4. Surgical Exposure and Cardiopulmonary Bypass

4.1. Operative Access

The standard operation uses median sternotomy, cardiopulmonary bypass, and cardioplegic arrest. After pericardial opening, the ascending aorta and right atrium are exposed, followed by appropriate central arterial and venous cannulation.

The ascending aorta is cross-clamped and myocardial protection established. A transverse or oblique aortotomy provides access to the aortic valve and LVOT, selected according to root dimensions and surgeon preference.

4.2. Transaortic Visualization

Inspect the three aortic cusps and gently retract them as needed. Particular care is required around the right and noncoronary cusp region and underlying membranous septum.

Fine retractors and appropriately sized instruments improve visualization while minimizing cusp traction.

Adequate visualization must precede tissue division. The membrane should be inspected around its complete circumference rather than focusing only on its most prominent ridge.

5. Membrane Resection: High and Low Lesions

5.1. High Subaortic Membrane

A high membrane lies immediately beneath the aortic valve and often approaches the cusp hinge regions. Its short distance from the cusps allows direct transaortic visualization but limits the safe dissection margin.

The surgeon identifies a controlled plane between abnormal fibrous tissue and adjacent endocardium or valve attachments. Excision proceeds progressively around the ridge. When tissue extends onto the ventricular aspect of a leaflet, careful sharp dissection avoids sacrificing normal cusp tissue.

The objective is complete obstruction relief with preserved cusp mobility and commissural geometry.

5.2. Low Subaortic Membrane

A lower membrane lies farther beneath the valve and may require deeper instrument access through the annulus. It may coexist with muscular hypertrophy or a longer segment of LVOT narrowing.

The surgeon must determine whether obstruction is predominantly fibrous or has an important muscular component. Purely fibrous lesions may be treated by membrane excision alone; significant residual muscular narrowing may justify selective myectomy.

A low membrane does not automatically require myectomy.

5.3. Step-by-Step Excision

  1. Identify the lesion: Inspect its circumferential boundaries and relationships to the aortic cusps, mitral leaflet, and membranous septum.
  2. Establish the dissection plane: Elevate the membrane gently where feasible and distinguish fibrous tissue from underlying endocardium.
  3. Divide the obstructing ridge: Make a controlled incision away from critical valve attachments.
  4. Extend the excision: Release pathological tissue progressively while minimizing traction and avoiding deep myocardial entry.
  5. Inspect the residual LVOT: Look for fibrous extensions along the septum and aortomitral continuity.
  6. Assess muscular narrowing: Determine whether selective septal myectomy would improve the residual lumen.
  7. Complete the inspection: Reassess the aortic cusps, anterior mitral leaflet, and ventricular septum.

The extent of circumferential resection is dictated by anatomy and tissue safety, not by an absolute requirement to remove every adjacent fibrous structure. [1,2]

6. Selective Septal Myectomy

6.1. Rationale and Indications

Myectomy is considered when basal septal muscle contributes to fixed LVOT narrowing or membrane excision leaves a restrictive muscular channel. The goal is limited enlargement of the LVOT rather than the extensive myectomy used for hypertrophic obstructive cardiomyopathy.

Resection boundaries should reflect septal thickness, outflow geometry, and neighboring conduction and valvular structures.

6.2. Technical Considerations and Evidence

Myectomy is directed toward the obstructive muscular component while avoiding the membranous septum. Excessive depth may cause ventricular septal perforation, conduction injury, or myocardial dysfunction.

Routine myectomy for every subaortic membrane remains controversial. A retrospective study of 107 pediatric patients undergoing membrane excision with routine myectomy reported reoperation in 16% of those with follow-up, and five patients required pacemaker implantation. Routine myectomy did not clearly improve reoperation rates compared with historical controls. [5]

Other surgical series have reported favorable results using combined resection and myectomy, but these retrospective datasets do not establish a universally superior approach. [7]

7. Completion Assessment and Postoperative Management

7.1. Intraoperative Assessment

The LVOT should be reinspected for residual fibrous tissue, remaining muscular narrowing, and unintended structural injury. Aortic cusp mobility and anterior mitral leaflet integrity must be confirmed before closure.

After aortotomy closure, de-airing, and separation from bypass, transesophageal echocardiography evaluates:

  • Residual fixed LVOT obstruction and flow acceleration.
  • New or worsened aortic regurgitation.
  • Mitral valve competence.
  • Ventricular septal integrity.
  • Left ventricular systolic function.
  • Other associated residual lesions.

A persistent gradient should be interpreted with attention to cardiac output, loading conditions, possible dynamic obstruction, and residual fixed narrowing. The decision to return to bypass depends on the complete anatomical and hemodynamic assessment.

7.2. Early Postoperative Management

Continuous electrocardiographic monitoring is indicated for atrioventricular block, new bundle branch abnormalities, and junctional rhythms. Echocardiography should reassess obstruction, valve function, and ventricular performance.

Preoperative pressure-overload hypertrophy may cause impaired relaxation and altered preload tolerance. Significant residual obstruction, new important regurgitation, or septal injury requires prompt evaluation.

8. Long-Term Outcomes and Recurrence

8.1. Recurrent Subaortic Stenosis

Recurrent obstruction may reflect fibrous tissue regrowth, persistent abnormal LVOT flow geometry, or progression of fibromuscular narrowing. Published recurrence and reintervention rates differ with morphology, surgical techniques, follow-up, and outcome definitions.

In a retrospective 120-patient series, recurrence occurred in 18% and freedom from reintervention at 10 years was approximately 90%. Higher preoperative LVOT gradients and bicuspid aortic valve predicted reintervention. [7]

Another long-term pediatric series reported reoperation for recurrence in 21% over a median follow-up of 10.9 years. [8]

8.2. Progressive Aortic Regurgitation

Aortic regurgitation may reflect preexisting cusp involvement, chronic jet-related injury, progressive valvular abnormalities, or operative injury. It may remain stable or progress despite technically adequate membrane removal.

In the 120-patient series, mild or moderate aortic regurgitation was present in 49% at latest follow-up. [7] Removal of obstruction cannot necessarily reverse established aortic cusp pathology.

8.3. Surveillance

Serial echocardiographic follow-up should assess membrane recurrence, LVOT Doppler gradients, aortic regurgitation, LV hypertrophy and function, and associated lesions. Follow-up continues from childhood into adult congenital care.

Younger age, complex morphology, significant preoperative gradient, chromosomal anomalies, and residual obstruction may justify closer surveillance. [5,6,9] Reoperation is considered when recurrent obstruction becomes hemodynamically important or causes symptoms, ventricular consequences, or progressive valve dysfunction.

9. Key Surgical Principles

  • Anatomical definition: Establish the membrane's relationships to the aortic cusps, anterior mitral leaflet, septum, and conduction axis.
  • Controlled transaortic exposure: Avoid traumatic cusp manipulation.
  • Precise excision: Remove obstructing tissue without disrupting normal valve attachments.
  • Selective myectomy: Address significant muscular narrowing while preserving septal and conduction integrity.
  • Completion assessment: Exclude residual obstruction, valvular injury, septal injury, and ventricular dysfunction.
  • Long-term surveillance: Anticipate possible recurrence and progression of aortic regurgitation.

10. Conclusion

Transaortic membrane resection is the principal surgical treatment for discrete subaortic stenosis. Anatomic understanding and measured excision are essential to achieve complete LVOT relief without injuring the aortic valve, anterior mitral leaflet, ventricular septum, or conduction system.

Selective septal myectomy is appropriate when significant muscular narrowing remains, but routine myectomy has not been established as superior for all patients. Even after an effective initial result, recurrent obstruction and progressive aortic regurgitation require long-term follow-up.

References

  1. Dearani J, Croti U, Price TN, et al. Subvalvular aortic membrane resection. Rev Bras Cir Cardiovasc. 2011. DOI: 10.1590/S0102-76382011000100024. PMID: 21881724.
  2. Hraska V, Photiadis J, Arenz C. Surgery for subvalvar aortic stenosis—resection of discrete subvalvar aortic membrane. Multimed Man Cardiothorac Surg. 2007. DOI: 10.1510/mmcts.2006.002303. PMID: 24414448.
  3. Kelly D, Wulfsberg E, Rowe RD. Discrete subaortic stenosis. Circulation. 1972;46:309–322. DOI: 10.1161/01.CIR.46.2.309. PMID: 5065262.
  4. Abushaban L, Uthaman B, Selvan J, et al. Long-term follow-up and outcomes of discrete subaortic stenosis resection in children. Ann Pediatr Cardiol. 2019. DOI: 10.4103/apc.APC_120_18. PMID: 31516277.
  5. Mazurek A, Yu S, Lowery R, Ohye R. Routine septal myectomy during subaortic stenosis membrane resection: effect on recurrence rates. Pediatr Cardiol. 2018. DOI: 10.1007/s00246-018-1941-5. PMID: 30310939.
  6. Geva A, McMahon C, Gauvreau K, et al. Risk factors for reoperation after repair of discrete subaortic stenosis in children. J Am Coll Cardiol. 2007. DOI: 10.1016/j.jacc.2007.07.013. PMID: 17919571.
  7. Bandara D, Salve G, Marathe S, et al. Mid- and long-term outcomes after surgical correction of subaortic stenosis: a 27-year experience. Eur J Cardiothorac Surg. 2023. DOI: 10.1093/ejcts/ezad314. PMID: 37707826.
  8. Pickard SS, Geva A, Gauvreau K, et al. Long-term outcomes and risk factors for aortic regurgitation after discrete subvalvular aortic stenosis resection in children. Heart. 2015. DOI: 10.1136/heartjnl-2015-307460. PMID: 26238147.
  9. Carlson L, Pickard SS, Gauvreau K, et al. Preoperative factors that predict recurrence after repair of discrete subaortic stenosis. Ann Thorac Surg. 2020. DOI: 10.1016/j.athoracsur.2020.05.140. PMID: 32712099.